GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioptik Technology Inc (ROCO:4161) » Definitions » Price-to-Owner-Earnings

Bioptik Technology (ROCO:4161) Price-to-Owner-Earnings : 15.43 (As of May. 28, 2025)


View and export this data going back to 2013. Start your Free Trial

What is Bioptik Technology Price-to-Owner-Earnings?

As of today (2025-05-28), Bioptik Technology's share price is NT$30.85. Bioptik Technology's Owner Earnings per Share (TTM) ended in Mar. 2025 was NT$2.00. It's Price-to-Owner-Earnings for today is 15.43.


The historical rank and industry rank for Bioptik Technology's Price-to-Owner-Earnings or its related term are showing as below:

ROCO:4161' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 8.53   Med: 15.55   Max: 113.55
Current: 15.56

During the past 13 years, the highest Price-to-Owner-Earnings of Bioptik Technology was 113.55. The lowest was 8.53. And the median was 15.55.


ROCO:4161's Price-to-Owner-Earnings is ranked better than
74.66% of 292 companies
in the Medical Devices & Instruments industry
Industry Median: 27.955 vs ROCO:4161: 15.56

As of today (2025-05-28), Bioptik Technology's share price is NT$30.85. Bioptik Technology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was NT$1.74. Therefore, Bioptik Technology's PE Ratio (TTM) for today is 17.73.

As of today (2025-05-28), Bioptik Technology's share price is NT$30.85. Bioptik Technology's EPS without NRI for the trailing twelve months (TTM) ended in was NT$1.74. Therefore, Bioptik Technology's PE Ratio without NRI for today is 17.76.

During the past 13 years, Bioptik Technology's highest PE Ratio without NRI was 2078.23. The lowest was 14.40. And the median was 59.19.


Bioptik Technology Price-to-Owner-Earnings Historical Data

The historical data trend for Bioptik Technology's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioptik Technology Price-to-Owner-Earnings Chart

Bioptik Technology Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 108.73 8.97 11.65

Bioptik Technology Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.22 17.29 16.52 11.65 17.03

Competitive Comparison of Bioptik Technology's Price-to-Owner-Earnings

For the Medical Devices subindustry, Bioptik Technology's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioptik Technology's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bioptik Technology's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Bioptik Technology's Price-to-Owner-Earnings falls into.


;
;

Bioptik Technology Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Bioptik Technology's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=30.85/2.00
=15.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioptik Technology  (ROCO:4161) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Bioptik Technology Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Bioptik Technology's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioptik Technology Business Description

Traded in Other Exchanges
N/A
Address
No.188, Zhonghua South Road, Miaoli County, Zhunan, TWN, 35057
Bioptik Technology Inc is a Taiwan-based company engaged in the research, development, production, and sale of medical devices and reagents. The company is also focused on developing skin care products and aims to engage in developing bioenergy, Astaxanthin, and Cellulose Bioethanol. It is involved in the business areas of Home care medical devices, Skincare- Its own brand, Dietary supplement OEM and ODM, Skincare- OEM and ODM, and Biodiesel. In the Home care business area, the company provides Easy Touch blood glucose monitoring, and blood cholesterol and uric acid monitoring systems, as well as its strips.

Bioptik Technology Headlines

No Headlines